Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

14.29 (USD) • At close February 4, 2025
Bedrijfsnaam Ginkgo Bioworks Holdings, Inc.
Symbool DNA
Munteenheid USD
Prijs 14.29
Beurswaarde 821,373,595
Dividendpercentage 0%
52-weken bereik 5.26 - 64.4
Industrie Biotechnology
Sector Healthcare
CEO Dr. Jason Kelly
Website https://www.ginkgobioworks.com

An error occurred while fetching data.

Over Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products,

Vergelijkbare Aandelen

Teladoc Health, Inc. logo

Teladoc Health, Inc.

TDOC

10.4 USD

Inspire Medical Systems, Inc. logo

Inspire Medical Systems, Inc.

INSP

197.38 USD

Perrigo Company plc logo

Perrigo Company plc

PRGO

25.09 USD

Penumbra, Inc. logo

Penumbra, Inc.

PEN

262.11 USD

AMN Healthcare Services, Inc. logo

AMN Healthcare Services, Inc.

AMN

26.7 USD

Bausch + Lomb Corporation logo

Bausch + Lomb Corporation

BLCO

17.5 USD

Stevanato Group S.p.A. logo

Stevanato Group S.p.A.

STVN

22.54 USD

Encompass Health Corporation logo

Encompass Health Corporation

EHC

101.16 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)